S&P 500   3,952.47 (+0.47%)
DOW   33,663.08 (+0.19%)
QQQ   283.40 (+1.02%)
AAPL   142.37 (+1.01%)
MSFT   246.96 (+1.06%)
META   115.70 (+1.55%)
GOOGL   94.18 (-0.80%)
AMZN   90.17 (+1.93%)
TSLA   173.31 (-0.42%)
NVDA   170.08 (+5.51%)
NIO   13.35 (+6.12%)
BABA   94.02 (+6.44%)
AMD   69.92 (-0.31%)
T   19.14 (-0.83%)
MU   55.15 (+2.47%)
CGC   3.01 (-7.10%)
F   13.12 (+0.15%)
GE   83.43 (-1.85%)
DIS   92.48 (+0.36%)
AMC   6.18 (+2.15%)
PYPL   74.50 (+0.11%)
PFE   51.52 (+2.55%)
NFLX   309.17 (+0.24%)
S&P 500   3,952.47 (+0.47%)
DOW   33,663.08 (+0.19%)
QQQ   283.40 (+1.02%)
AAPL   142.37 (+1.01%)
MSFT   246.96 (+1.06%)
META   115.70 (+1.55%)
GOOGL   94.18 (-0.80%)
AMZN   90.17 (+1.93%)
TSLA   173.31 (-0.42%)
NVDA   170.08 (+5.51%)
NIO   13.35 (+6.12%)
BABA   94.02 (+6.44%)
AMD   69.92 (-0.31%)
T   19.14 (-0.83%)
MU   55.15 (+2.47%)
CGC   3.01 (-7.10%)
F   13.12 (+0.15%)
GE   83.43 (-1.85%)
DIS   92.48 (+0.36%)
AMC   6.18 (+2.15%)
PYPL   74.50 (+0.11%)
PFE   51.52 (+2.55%)
NFLX   309.17 (+0.24%)
S&P 500   3,952.47 (+0.47%)
DOW   33,663.08 (+0.19%)
QQQ   283.40 (+1.02%)
AAPL   142.37 (+1.01%)
MSFT   246.96 (+1.06%)
META   115.70 (+1.55%)
GOOGL   94.18 (-0.80%)
AMZN   90.17 (+1.93%)
TSLA   173.31 (-0.42%)
NVDA   170.08 (+5.51%)
NIO   13.35 (+6.12%)
BABA   94.02 (+6.44%)
AMD   69.92 (-0.31%)
T   19.14 (-0.83%)
MU   55.15 (+2.47%)
CGC   3.01 (-7.10%)
F   13.12 (+0.15%)
GE   83.43 (-1.85%)
DIS   92.48 (+0.36%)
AMC   6.18 (+2.15%)
PYPL   74.50 (+0.11%)
PFE   51.52 (+2.55%)
NFLX   309.17 (+0.24%)
S&P 500   3,952.47 (+0.47%)
DOW   33,663.08 (+0.19%)
QQQ   283.40 (+1.02%)
AAPL   142.37 (+1.01%)
MSFT   246.96 (+1.06%)
META   115.70 (+1.55%)
GOOGL   94.18 (-0.80%)
AMZN   90.17 (+1.93%)
TSLA   173.31 (-0.42%)
NVDA   170.08 (+5.51%)
NIO   13.35 (+6.12%)
BABA   94.02 (+6.44%)
AMD   69.92 (-0.31%)
T   19.14 (-0.83%)
MU   55.15 (+2.47%)
CGC   3.01 (-7.10%)
F   13.12 (+0.15%)
GE   83.43 (-1.85%)
DIS   92.48 (+0.36%)
AMC   6.18 (+2.15%)
PYPL   74.50 (+0.11%)
PFE   51.52 (+2.55%)
NFLX   309.17 (+0.24%)
NYSE:CLB

Core Laboratories - CLB Stock Forecast, Price & News

$18.99
+0.27 (+1.44%)
(As of 12/8/2022 02:42 PM ET)
Add
Compare
Today's Range
$18.92
$19.64
50-Day Range
$13.48
$23.02
52-Week Range
$13.19
$35.83
Volume
10,830 shs
Average Volume
332,278 shs
Market Capitalization
$880.57 million
P/E Ratio
57.55
Dividend Yield
0.20%
Price Target
$19.58

Core Laboratories MarketRank™ Forecast

Analyst Rating
Reduce
1.33 Rating Score
Upside/​Downside
2.9% Upside
$19.58 Price Target
Short Interest
Bearish
8.87% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
151.43%
From $0.35 to $0.88 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.47 out of 5 stars

Oils/Energy Sector

231st out of 246 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

20th out of 20 stocks

CLB stock logo

About Core Laboratories (NYSE:CLB) Stock

Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock News Headlines

Core Labs (CLB) Q3 Earnings Surpass Estimates, Sales Meet
Schlumberger (SLB) Tops Q3 Earnings and Revenue Estimates
Today's Stock Upgrades of Note
Today's Downgrades of Note
Core Laboratories N.V. (CLB)
SLB vs. CLB: Which Stock Is the Better Value Option?
Core Laboratories: A Speculative Buy At Present Levels
SLB or CLB: Which Is the Better Value Stock Right Now?
Core Laboratories goes ex-dividend tomorrow
Why Energy Stocks Dropped on Monday
See More Headlines
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Company Calendar

Last Earnings
10/26/2022
Ex-Dividend for 11/28 Dividend
11/04/2022
Dividend Payable
11/28/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/01/2023

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,700
Year Founded
1936

Price Target and Rating

Average Stock Price Forecast
$19.58
High Stock Price Forecast
$21.30
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+3.1%
Consensus Rating
Reduce
Rating Score (0-4)
1.33
Research Coverage
3 Analysts

Profitability

Net Income
$19.73 million
Pretax Margin
5.96%

Debt

Sales & Book Value

Annual Sales
$470.25 million
Cash Flow
$1.08 per share
Book Value
$3.48 per share

Miscellaneous

Free Float
46,176,000
Market Cap
$880.57 million
Optionable
Optionable
Beta
2.64

Social Links


Key Executives

  • Mr. Lawrence V. Bruno (Age 62)
    Chairman, CEO, Pres & COO
    Comp: $1.61M
  • Mr. Christopher Scott Hill (Age 52)
    Sr. VP & CFO
    Comp: $702.65k
  • Ms. Gwendolyn Y. Gresham M.B.A. (Age 54)
    Sr. VP of Corp. Devel. & Investor Relations
    Comp: $612.71k
  • Mr. Mark Damian Tattoli (Age 50)
    Sr. VP, Sec. & Gen. Counsel
    Comp: $948.9k
  • Mr. Kevin G. Daniels (Age 58)
    Chief Accounting Officer, Treasurer & VP
  • Mr. Jacobus Schouten (Age 67)
    Managing Director
  • J. Donald Dumas Jr.
    Sr. VP of Production Enhancement & Bus. Devel.













CLB Stock - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last twelve months. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "sell" CLB shares.
View CLB analyst ratings
or view top-rated stocks.

What is Core Laboratories' stock price forecast for 2023?

3 analysts have issued 12 month price objectives for Core Laboratories' shares. Their CLB share price forecasts range from $17.00 to $21.30. On average, they anticipate the company's share price to reach $19.58 in the next twelve months. This suggests a possible upside of 4.6% from the stock's current price.
View analysts price targets for CLB
or view top-rated stocks among Wall Street analysts.

How have CLB shares performed in 2022?

Core Laboratories' stock was trading at $22.31 at the start of the year. Since then, CLB shares have decreased by 16.1% and is now trading at $18.72.
View the best growth stocks for 2022 here
.

When is Core Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our CLB earnings forecast
.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) released its earnings results on Wednesday, October, 26th. The oil and gas company reported $0.18 earnings per share for the quarter, beating analysts' consensus estimates of $0.09 by $0.09. The oil and gas company had revenue of $125.97 million for the quarter, compared to analysts' expectations of $126.14 million. Core Laboratories had a trailing twelve-month return on equity of 15.71% and a net margin of 3.16%.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories announced a quarterly dividend on Wednesday, October 26th. Shareholders of record on Monday, November 7th will be given a dividend of $0.01 per share on Monday, November 28th. This represents a $0.04 annualized dividend and a yield of 0.21%. The ex-dividend date of this dividend is Friday, November 4th.
Read our dividend analysis for CLB
.

Is Core Laboratories a good dividend stock?

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.20%. The dividend payout ratio is 12.12%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 4.55% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories issued an update on its fourth quarter 2022 earnings guidance on Wednesday, November, 2nd. The company provided EPS guidance of $0.17-$0.21 for the period, compared to the consensus EPS estimate of $0.17. The company issued revenue guidance of $126.00 million-$131.00 million, compared to the consensus revenue estimate of $129.98 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.01%), Vanguard Group Inc. (11.09%), Fred Alger Management LLC (8.82%), Boston Trust Walden Corp (4.34%), State Street Corp (2.81%) and Van ECK Associates Corp (2.67%). Insiders that own company stock include Jan Willem Sodderland, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $18.72.

How much money does Core Laboratories make?

Core Laboratories (NYSE:CLB) has a market capitalization of $868.05 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.33 on an earnings per share basis.

How many employees does Core Laboratories have?

The company employs 3,700 workers across the globe.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com.

This page (NYSE:CLB) was last updated on 12/8/2022 by MarketBeat.com Staff